Literature DB >> 1780806

Influence of anticoagulants used for blood collection on plasma prothrombin fragment F1 + 2 measurements.

K A Bauer1, S Barzegar, R D Rosenberg.   

Abstract

The levels of prothrombin fragment F1 + 2 were measured by a double antibody radioimmunoassay in blood samples collected into different anticoagulant solutions. We evaluated healthy males between the ages of 42 and 77, asymptomatic patients with hereditary deficiencies of protein C or protein S, and persons receiving tumor necrosis factor infusions. The results in specimens collected in an anticoagulant containing ACD, EDTA, adenosine, and 25 U/ml of heparin (a) were highly correlated with those collected in an anticoagulant containing a synthetic thrombin inhibitor, EDTA, and aprotinin (b). However, in asymptomatic patients with congenital antithrombin III deficiency, we found that the plasma levels of F1 + 2 in blood collected in anticoagulant (a) were usually substantially higher than those collected in anticoagulant (b). We determined that this phenomenon was not attributable to the venipuncture procedure itself, but rather appears to be due to the action of low concentrations of heparin in the presence of reduced blood levels of antithrombin III. Our data show that the previously documented elevations in plasma F1 + 2 levels in patients with congenital antithrombin III deficiency appear to be caused by the above in vitro anticoagulant effect, and that this population does not exhibit evidence of a prethrombotic state as defined by the F1 + 2 assay.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1780806     DOI: 10.1016/0049-3848(91)90088-e

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  2 in total

1.  Markers of thrombin and plasmin generation in patients with inherited thrombophilia.

Authors:  L H Lee; I Jennings; R Luddington; T Baglin
Journal:  J Clin Pathol       Date:  1994-07       Impact factor: 3.411

2.  Short-term effects of air pollution: a panel study of blood markers in patients with chronic pulmonary disease.

Authors:  Katharina Hildebrandt; Regina Rückerl; Wolfgang Koenig; Alexandra Schneider; Mike Pitz; Joachim Heinrich; Victor Marder; Mark Frampton; Günter Oberdörster; H Erich Wichmann; Annette Peters
Journal:  Part Fibre Toxicol       Date:  2009-09-26       Impact factor: 9.400

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.